A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer
Richard D. Kim, Bence Kővári, María Carmen Riesco Martínez, Hao Xie, İbrahim Halil Şahin, Rutika Mehta, Jonathan Strosberg, Iman Imanirad, Masoumeh Ghayouri, Youngchul Kim, Dae Won Kim
Topics & Concepts
RegorafenibNivolumabColorectal cancerRefractory (planetary science)MedicineOncologyInternal medicinePhase (matter)CancerMaterials scienceChemistryImmunotherapyComposite materialOrganic chemistryGenetic factors in colorectal cancerCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies